Production (Stage)
Microbix Biosystems Inc.
MBX.TO
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -62.36% | -49.16% | 15,147.09% | 301.63% | 480.29% |
| Total Depreciation and Amortization | 24.54% | 35.77% | 53.74% | 36.96% | 28.91% |
| Total Amortization of Deferred Charges | -51.45% | -51.45% | -75.43% | -2.72% | -2.72% |
| Total Other Non-Cash Items | 148.12% | 149.35% | 148.85% | -294.50% | -281.17% |
| Change in Net Operating Assets | 60.63% | 64.54% | -732.27% | -393.86% | -603.46% |
| Cash from Operations | 34.14% | 294.05% | 496.47% | 294.26% | 127.04% |
| Capital Expenditure | -36.25% | -93.63% | -59.84% | 29.38% | 54.31% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -62.68% | -122.59% | -86.09% | 16.95% | 54.31% |
| Total Debt Issued | -- | -- | -- | -97.80% | -97.80% |
| Total Debt Repaid | -470.13% | -77.41% | -73.38% | -65.21% | 64.68% |
| Issuance of Common Stock | 666.88% | 353.37% | 245.16% | -38.33% | -45.35% |
| Repurchase of Common Stock | -116.06% | -71.46% | 17.04% | 13.83% | -5.44% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 13.75% | -552.92% | -574.51% | -208.14% | -221.09% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 38.13% | -24.51% | 171.73% | 18.62% | 397.64% |